SCHEMBL19522683

SCHEMBL19522683

CBc1ccc(F)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.39
▸ PTGS2 P35354 2/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ TSHR P16473 3/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ DAPK3 O43293 1/20 0.32
▸ NTRK1 P04629 1/20 0.32
▸ PIM1 P11309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21912591 0.81 ACHE (0.39) ACHEPTGS2SMN1; SMN2TSHRPTGS1
SCHEMBL8272774 0.77 ALDH1A1 (0.42) ACHESMN1; SMN2TSHRMEN1KMT2A
SCHEMBL13811027 0.74 MAP4K4 (0.40) SMN1; SMN2TSHRALDH1A1LMNAMAPT
SCHEMBL14403319 0.71 TP53 (0.52) ALDH1A1MAPT
SCHEMBL12849546 0.70 KDM1A (0.37) —
SCHEMBL168684 0.69 — —
SCHEMBL91411 0.69 — —
SCHEMBL29370717 0.69 — —
SCHEMBL24283462 0.68 ALDH1A1 (0.40) TSHRALDH1A1SLC6A4
SCHEMBL12319312 0.68 ERN1 (0.36) TSHRMEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4209230-A1 MESOPOROUS SILICA NANOPARTICLE CONTROLLED RELEASE SYSTEM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF East China University of Science and Technology (CN) 2023-07-12 — — EP disclosed
US-9801882-B2 Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases INTRA-CELLULAR THERAPIES, INC. (US) 2017-10-31 — — US disclosed
Send feedback